These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The art of modeling adherence: shades or shapes? Parienti JJ Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1114-6. PubMed ID: 26183118 [No Abstract] [Full Text] [Related]
4. CRP and statins for primary prevention of coronary artery disease. Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):97-8; quiz p following 104. PubMed ID: 19078864 [No Abstract] [Full Text] [Related]
6. Lipid lowering, statins and cancer. Wierzbicki AS Int J Clin Pract; 2006 Sep; 60(9):1022-4. PubMed ID: 16939539 [No Abstract] [Full Text] [Related]
7. Genetic determinants of response to statins. Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675 [TBL] [Abstract][Full Text] [Related]
8. Statins and cancer in patients with asthma. Mascitelli L; Pezzetta F; Goldstein MR Thorax; 2009 Jun; 64(6):548-9; author reply 549. PubMed ID: 19478124 [No Abstract] [Full Text] [Related]
9. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels. Celik M; Celik T Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663 [No Abstract] [Full Text] [Related]
10. [Cancer patients should not be treated with statins]. Ravnskov U Ugeskr Laeger; 2013 Jan; 175(1-2):76. PubMed ID: 23441320 [No Abstract] [Full Text] [Related]
11. Use of statins in healthy men. Beckman JA JAMA; 2012 Aug; 308(7):666; author reply 666-7. PubMed ID: 22893156 [No Abstract] [Full Text] [Related]
12. Prevention and treatment: a tale of two strategies. Diamond GA; Kaul S J Am Coll Cardiol; 2008 Jan; 51(1):46-8. PubMed ID: 18174035 [No Abstract] [Full Text] [Related]
13. [Coronary artery disease prevention: still a long way to go...]. Danchin N Ann Cardiol Angeiol (Paris); 2008 Feb; 57 Suppl 1():1. PubMed ID: 18472026 [No Abstract] [Full Text] [Related]
14. T helper 1/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: statins as immunomodulatory agents? Shimada K; Park JK; Daida H Eur Heart J; 2006 Dec; 27(24):2916-8. PubMed ID: 17098759 [No Abstract] [Full Text] [Related]
15. Statin treatment does not cause cancer. Steinberg D J Am Coll Cardiol; 2008 Sep; 52(14):1148-9. PubMed ID: 18804741 [No Abstract] [Full Text] [Related]
16. The informed patient. DeMaria AN J Am Coll Cardiol; 2008 Apr; 51(15):1505-6. PubMed ID: 18402907 [No Abstract] [Full Text] [Related]
17. Statins for all. Spence D BMJ; 2014 Mar; 348():g1899. PubMed ID: 24589618 [No Abstract] [Full Text] [Related]
18. The power of statins: aggressive lipid lowering. Jones PH Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597 [TBL] [Abstract][Full Text] [Related]
19. Recapturing the magic: revisiting the pleiotropic effects of statins in percutaneous coronary revascularization. Ellis SG; Anwaruddin S J Am Coll Cardiol; 2009 Aug; 54(6):566-8. PubMed ID: 19643321 [No Abstract] [Full Text] [Related]
20. [Immunomodulatory properties of statins and cancer risk]. Mascitelli L; Goldstein MR; Pezzetta F Recenti Prog Med; 2009 Jan; 100(1):33-9. PubMed ID: 19445281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]